The global laboratory freezers market is projected to reach USD 5.11 billion by 2031 from USD 4.32 billion in 2026, at a CAGR of 3.5% from 2026 to 2031.
The laboratory freezers market is primarily driven by the increasing need for reliable, temperature-controlled storage of vaccines, biological samples, reagents, blood components, cell lines, tissues, and other temperature-sensitive materials. The rapid expansion of pharmaceutical and biotechnology research, vaccine development, clinical diagnostics, biobanking, genomics, and cell and gene therapy is accelerating the adoption of advanced laboratory freezers across research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and biobanks. In addition, stringent regulatory and quality requirements for maintaining sample integrity and cold-chain compliance are encouraging end users to adopt freezers equipped with precise temperature control, continuous monitoring, automated data logging, remote alarms, and backup systems. Furthermore, increasing investments in healthcare and life-science infrastructure, the expansion of biorepositories, and growing demand for ultra-low-temperature storage are supporting market growth. Manufacturers are also introducing energy-efficient compressors, environmentally sustainable refrigerants, improved insulation, automated inventory management, and IoT-enabled monitoring systems to reduce operating costs, minimize sample-loss risks, and enhance laboratory workflow efficiency, thereby driving sustained growth of the laboratory freezers market.
By end user, pharmaceutical & biotechnology companies accounted for the largest share in the forecast period.
By end user, the laboratory freezers market is segmented into hospitals, clinical & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, pharmacies & physicians’ offices, and cell & tissue banks. Pharmaceutical & biotechnology companies accounted for the largest market share due to their extensive requirement for controlled-temperature storage across drug discovery, vaccine development, biologics manufacturing, clinical trials, quality control, and commercial production. These companies store substantial volumes of temperature-sensitive materials, including vaccines, biologics, cell lines, genetic material, reagents, active pharmaceutical ingredients, reference standards, and clinical-trial samples. Rising investment in biopharmaceutical R&D, expanding biologics and biosimilar pipelines, and the development of cell and gene therapies are further increasing demand for refrigerators, ultra-low-temperature freezers, and cryopreservation systems. Moreover, stringent regulatory requirements for sample integrity, temperature monitoring, data logging, alarm management, backup systems, and storage validation support the segment’s leading market position.
The laboratory freezers market is primarily driven by the increasing need for reliable, temperature-controlled storage of vaccines, biological samples, reagents, blood components, cell lines, tissues, and other temperature-sensitive materials. The rapid expansion of pharmaceutical and biotechnology research, vaccine development, clinical diagnostics, biobanking, genomics, and cell and gene therapy is accelerating the adoption of advanced laboratory freezers across research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and biobanks. In addition, stringent regulatory and quality requirements for maintaining sample integrity and cold-chain compliance are encouraging end users to adopt freezers equipped with precise temperature control, continuous monitoring, automated data logging, remote alarms, and backup systems. Furthermore, increasing investments in healthcare and life-science infrastructure, the expansion of biorepositories, and growing demand for ultra-low-temperature storage are supporting market growth. Manufacturers are also introducing energy-efficient compressors, environmentally sustainable refrigerants, improved insulation, automated inventory management, and IoT-enabled monitoring systems to reduce operating costs, minimize sample-loss risks, and enhance laboratory workflow efficiency, thereby driving sustained growth of the laboratory freezers market.
By product, refrigerators accounted for the largest share of the laboratory freezers market in 2025
By product, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. Refrigerators account for the largest market share due to their widespread use for the routine storage of vaccines, reagents, culture media, pharmaceutical products, blood samples, and other temperature-sensitive materials at controlled temperatures, typically between 2°C and 8°C. Their extensive installation across hospitals, diagnostic laboratories, blood banks, pharmacies, research institutes, and pharmaceutical and biotechnology companies generates strong and recurring demand. Compared with ultra-low-temperature freezers and cryopreservation systems, laboratory refrigerators offer lower acquisition and operating costs, simpler maintenance, and broader applicability in everyday laboratory workflows. Furthermore, expanding diagnostic testing, vaccine programs, clinical research, and pharmaceutical production—along with stringent requirements for temperature stability, continuous monitoring, automated data logging, and regulatory compliance are supporting the segment’s leading position. Growing adoption of energy-efficient, environmentally sustainable, and IoT-enabled refrigerators with remote alarms and backup controls is expected to further drive segment growth.By application, the pharmaceutical & vaccine storage segment accounted for the largest share of the laboratory freezers market
By application, the laboratory freezers market is segmented into environmental testing, genetic material storage, pharmaceutical & vaccine storage, biological samples & inventory management, and other applications. The pharmaceutical & vaccine storage segment accounted for the largest market share owing to the substantial volume of temperature-sensitive vaccines, biologics, drugs, active pharmaceutical ingredients, reagents, and clinical-trial materials requiring controlled storage. The expansion of vaccine manufacturing and immunization programs, increasing production of biologics and specialty medicines, and growth in pharmaceutical research and clinical trials are creating strong demand for laboratory refrigerators and freezers. Furthermore, stringent regulatory requirements for temperature stability, continuous monitoring, data logging, alarm systems, backup power, and cold-chain compliance encourage pharmaceutical manufacturers, hospitals, pharmacies, research laboratories, and distribution centers to invest in reliable storage equipment. The recurring need to store pharmaceutical products across research, production, quality-control, and distribution workflows further reinforces the segment’s leading market position.By end user, pharmaceutical & biotechnology companies accounted for the largest share in the forecast period.
By end user, the laboratory freezers market is segmented into hospitals, clinical & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, pharmacies & physicians’ offices, and cell & tissue banks. Pharmaceutical & biotechnology companies accounted for the largest market share due to their extensive requirement for controlled-temperature storage across drug discovery, vaccine development, biologics manufacturing, clinical trials, quality control, and commercial production. These companies store substantial volumes of temperature-sensitive materials, including vaccines, biologics, cell lines, genetic material, reagents, active pharmaceutical ingredients, reference standards, and clinical-trial samples. Rising investment in biopharmaceutical R&D, expanding biologics and biosimilar pipelines, and the development of cell and gene therapies are further increasing demand for refrigerators, ultra-low-temperature freezers, and cryopreservation systems. Moreover, stringent regulatory requirements for sample integrity, temperature monitoring, data logging, alarm management, backup systems, and storage validation support the segment’s leading market position.
The Asia Pacific market is projected to show the highest growth rate in the laboratory freezers market
The laboratory freezers market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest growth rate, driven by the rapid expansion of pharmaceutical and biotechnology manufacturing, vaccine production, clinical research, diagnostic testing, and biobanking activities. Increasing healthcare expenditure, government investments in life-science infrastructure, and the establishment of new research laboratories, hospitals, and cold-chain facilities are strengthening demand for laboratory refrigerators, ultra-low-temperature freezers, and cryopreservation systems. The region is also benefiting from the growing production of biologics, biosimilars, and cell and gene therapies, particularly in China, India, Japan, and South Korea. Furthermore, increasing awareness of sample integrity, stricter temperature-control requirements, and rising adoption of energy-efficient and digitally connected storage systems are expected to accelerate regional market growth.A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
- By Designation: Directors (50%), Managers (30%), and Others (20%)
- By Region: North America (37%), Europe (25%), Asia Pacific (30%), Latin America (5%), and the Middle East & Africa (3%)
The major players in the laboratory freezers market include Thermo Fisher Scientific (US), Haier Biomedical (China), PHC Holdings (Japan), Eppendorf AG (Germany), and Avantor (US), among others
Research Coverage
The research report examines the laboratory freezers market by product, application, end user, and region. This research covers factors driving market expansion, analyzes prospects and parameters faced by industries today, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micromarket analysisReasons to Buy the Report
The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall laboratory freezers market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.This report provides insightful data on the following pointers:
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the laboratory freezers market
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the laboratory freezers market
- Market Development: Insightful data on profitable developing areas
- Market Diversification: Details about recent developments and advancements in the laboratory freezers market
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
Table of Contents
1 INTRODUCTION
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
4 MARKET OVERVIEW
5 INDUSTRY TRENDS
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,AND AI ADOPTION
7 REGULATORY LANDSCAPE
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
9 LABORATORY FREEZERS MARKET, BY PRODUCT
10 LABORATORY FREEZERS MARKET, BY APPLICATION
11 LABORATORY FREEZERS MARKET, BY END USER
12 LABORATORY FREEZERS MARKET, BY REGION
13 COMPETITIVE LANDSCAPE
14 COMPANY PROFILES
15 RESEARCH METHODOLOGY
16 APPENDIX
LIST OF TABLES
LIST OF FIGURES
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 230 |
| Published | July 2026 |
| Forecast Period | 2026 - 2031 |
| Estimated Market Value ( USD | $ 4.32 billion |
| Forecasted Market Value ( USD | $ 5.11 billion |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
